Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Safety and Efficacy of Percutaneous Coronary Intervention Combined With Thrombolysis by Recombinant Human Prourokinase at Different Time

NCT03137212 is registered in ClinicalTrials.gov with Second Hospital of Jilin University as lead sponsor.

NCT NCT03137212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03137212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Safety and Efficacy of Percutaneous Coronary Intervention Combined With Thrombolysis by Recombinant Human Prourokinase at Different Time
Lead sponsor
Second Hospital of Jilin University
Phase
Not applicable
Overall status
Unknown status
Start date
April 17, 2017
Completion date
March 31, 2020
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute st segment elevation myocardial infarction